Follow on Bluesky

Home
About RISK-HUNT3R
Partners & Collaborations
Publications
Resource centre
News and updates
ASPA
Contact
EU-ToxRisk Legacy

Home
About RISK-HUNT3R
Partners & Collaborations
Publications
Resource centre
News and updates
ASPA
Contact
EU-ToxRisk Legacy

Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccines

Aug 1, 2022 | 2020, Archives of Toxicology, Publication - legacy work

Search for:

Recent Posts

Registration is open for the 3rd RISK-HUNT3R stakeholder symposium
Causal, Predictive or Observational? Different Understandings of Key Event Relationships for Adverse Outcome Pathways and their implications on practice
Interdependency of estradiol-mediated ERα activation and subsequent PR and GREB1 induction to control cell cycle progression
The long way from raw data to NAM-based information: Overview on data layers and processing steps
Animal-free Safety Assessment of Chemicals: Project Cluster for Implementation of Novel Strategies (ASPIS) definition of new approach methodologies

Terms of Service

Legal Notice & Disclaimer
Privacy Policy
Copyright

Contact

mt|brightness_low|

riskhunt3r_contact
@eurtd.com

mt|brightness_low|

riskhunt3r_contact@eurtd.com

Search

Search for:

Follow us

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964537.

Copyright © RISK-HUNT3R 2025

EU Disclaimer: The content of this website reflects only the author’s view; the Commission is not responsible for any use that may be made of the information it contains.